Search alternatives:
teer decrease » greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
18681
-
18682
-
18683
-
18684
-
18685
-
18686
-
18687
-
18688
VisAccel complete data_redacted2.xlsx
Published 2025“…When the velocity profile of the visual stimulus matched the velocity profile of inertial motion, the inertial stimulus was biased 10.0 ± 1.8° (mean ± SE) with a 45° visual offset, 8.9 ± 1.7° with a 60° offset, and 9.3° ± 2.5 ± with a 75° offset. …”
-
18689
Supplementary Material for: A Systematic Review and Meta-Analysis of Molecular Biomarkers Associated with Early Neurological Deterioration Following Acute Stroke
Published 2018“…After classification into 3 broad categories, meta-analysis showed that biomarkers associated with increased END risk (n; fixed-effects mean difference; 95% CI) were “metabolic” (glucose [<i>n</i> = 9,481; 0.90 mmol/L; 0.74–1.06], glycosylated haemoglobin [<i>n</i> = 3,146; 0.33%; 0.19–0.46], low-density lipoprotein [<i>n</i> = 4,839; 0.13 mmol/L; 0.06–0.21], total cholesterol [<i>n</i> = 4,762; 0.21 mmol/L; 0.11–0.31], triglycerides [<i>n</i> = 4,820; 0.11 mmol/L; 0.06–0.17], urea [<i>n</i> = 1,351; 0.55 mmol/L; 0.14–0.96], decreasing albumin [<i>n</i> = 513; 0.33 g/dL; 0.05–0.61]); “inflammatory and excitotoxic” (plasma glutamate [<i>n</i> = 688; 60.13 µmol/L; 50.04–70.22], CSF glutamate [<i>n</i> = 369; 7.50 µmol/L; 6.76–8.23], homocysteine [<i>n</i> = 824; 2.15 µmol/L; 0.68–3.61], leucocytes [<i>n</i> = 3,766; 0.54 × 10<sup>9</sup>/L; 0.34–0.74], high-sensitivity C-reactive protein [<i>n</i> = 1,707; 3.79 mg/L; 1.23–6.35]); and “coagulation/haematological” (fibrinogen [<i>n</i> = 3,132; 0.32 g/L; 0.25–0.40]; decreasing haemoglobin [<i>n</i> = 3,586; 2.38 g/L; 0.15–4.60]). …”
-
18690
-
18691
-
18692
A single systemic prophylactic treatment with CpG-C results in long-term reduction of metastatic burden in the brain.
Published 2019“…Scale bar is 500 μm for the images on the left and middle, and 50 μm for the images on the right. (<b>c-f</b>) A single prophylactic systemic (i.p.) injection of 4 mg/kg CpG-C resulted in reduced growth of experimental brain metastases, as indicated by bioluminescence and fluorescence imaging. …”
-
18693
-
18694
Dynamics of soluble <i>Fgfr2b</i> expression and impact on AER maintenance after a single Dox-IP injection.
Published 2013“…(<b>C</b>) Quantification of <i>soluble Fgfr2b</i> by qRT-PCR indicating a peak of expression at 6 hrs and a steep decrease at 24 hrs. …”
-
18695
-
18696
Table_2_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx
Published 2022“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
-
18697
Table_1_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx
Published 2022“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
-
18698
Table_6_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.xlsx
Published 2022“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
-
18699
Table_3_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx
Published 2022“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
-
18700
Table_4_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx
Published 2022“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”